How MedTech Innovators Can Win Payer Coverage Outside Heart Failure, Cancer, and Diabetes

Published on: 16/11/2025

Think your device won’t get payer traction because it’s outside the “big three”? This article breaks down how MedTech companies targeting niche patient populations can still win with U.S. payers by aligning with quality metrics, cost savings, and equity priorities.

Payer Coverage
How MedTech Innovators Can Win Payer Coverage Outside Heart Failure, Cancer, and Diabetes

The Myth of the Perfect Study for U.S. Market Access

Published on: 12/08/2025

One study rarely unlocks full payer coverage. Learn why U.S. market access requires a portfolio of evidence, strategic sequencing, and payer-specific insights.

Evidence Planning
The Myth of the Perfect Study for U.S. Market Access

The Hidden Bias in Reimbursement: Why First Movers May Have It Easier

Published on: 06/02/2025

Why do better technologies struggle for reimbursement while outdated ones thrive? Discover the hidden bias in payer decision-making—and why second movers in MedTech face steeper evidence hurdles than the first.

Coding and PaymentEvidence PlanningFundamentalsFeatured
The Hidden Bias in Reimbursement: Why First Movers May Have It Easier